logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 5
  • 1
    Patel, Bemal
    Born in September 1973
    Individual (134 offsprings)
    Officer
    1999-11-26 ~ now
    OF - Director → CIF 0
  • 2
    Patel, Hital
    Born in December 1974
    Individual (19 offsprings)
    Officer
    2006-11-28 ~ now
    OF - Director → CIF 0
    Patel, Hital
    Individual (19 offsprings)
    Officer
    1999-11-26 ~ now
    OF - Secretary → CIF 0
  • 3
    PHARMADENT HOLDINGS LIMITED 07285506
    Haslers, Old Station Road, Loughton, Essex, England
    Active Corporate (3 parents, 12 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
  • 4
    FORM 10 DIRECTORS FD LTD
    03199791
    39a Leicester Road, Salford, Manchester, Lancashire
    Dissolved Corporate (5 parents, 78793 offsprings)
    Officer
    1999-11-25 ~ 1999-11-25
    OF - Nominee Director → CIF 0
  • 5
    FORM 10 SECRETARIES FD LTD
    03199793
    39a Leicester Road, Salford, Manchester, Lancashire
    Dissolved Corporate (5 parents, 74357 offsprings)
    Officer
    1999-11-25 ~ 1999-11-25
    OF - Nominee Secretary → CIF 0
parent relation
Company in focus

PHARMACEUTICALS DIRECT LIMITED

Period: 1999-11-25 ~ now
Company number: 03884028 08955378
Registered name
PHARMACEUTICALS DIRECT LIMITED - now 08955378
Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Average Number of Employees
262024-04-01 ~ 2025-03-31
222023-04-01 ~ 2024-03-31
Turnover/Revenue
25,193,894 GBP2024-04-01 ~ 2025-03-31
33,644,545 GBP2023-04-01 ~ 2024-03-31
Cost of Sales
-20,268,652 GBP2024-04-01 ~ 2025-03-31
-28,726,948 GBP2023-04-01 ~ 2024-03-31
Gross Profit/Loss
4,925,242 GBP2024-04-01 ~ 2025-03-31
4,917,597 GBP2023-04-01 ~ 2024-03-31
Administrative Expenses
-3,376,852 GBP2024-04-01 ~ 2025-03-31
-3,645,379 GBP2023-04-01 ~ 2024-03-31
Operating Profit/Loss
1,548,390 GBP2024-04-01 ~ 2025-03-31
1,272,218 GBP2023-04-01 ~ 2024-03-31
Profit/Loss on Ordinary Activities Before Tax
1,590,660 GBP2024-04-01 ~ 2025-03-31
1,265,842 GBP2023-04-01 ~ 2024-03-31
Profit/Loss
1,325,687 GBP2024-04-01 ~ 2025-03-31
942,252 GBP2023-04-01 ~ 2024-03-31
Intangible Assets
1,676 GBP2024-03-31
Property, Plant & Equipment
314,713 GBP2025-03-31
241,212 GBP2024-03-31
Fixed Assets - Investments
15,782,624 GBP2025-03-31
15,775,609 GBP2024-03-31
Fixed Assets
16,097,337 GBP2025-03-31
16,018,497 GBP2024-03-31
Total Inventories
6,588,600 GBP2025-03-31
4,905,610 GBP2024-03-31
Debtors
Current
26,809,228 GBP2025-03-31
27,572,229 GBP2024-03-31
Cash at bank and in hand
94,731 GBP2025-03-31
211,706 GBP2024-03-31
Current Assets
33,492,559 GBP2025-03-31
32,689,545 GBP2024-03-31
Creditors
Current, Amounts falling due within one year
-7,931,925 GBP2025-03-31
Net Current Assets/Liabilities
25,560,634 GBP2025-03-31
24,313,787 GBP2024-03-31
Total Assets Less Current Liabilities
41,657,971 GBP2025-03-31
40,332,284 GBP2024-03-31
Net Assets/Liabilities
36,973,555 GBP2025-03-31
35,647,868 GBP2024-03-31
Equity
Called up share capital
2,079,700 GBP2025-03-31
2,079,700 GBP2024-03-31
2,079,700 GBP2023-04-01
Retained earnings (accumulated losses)
34,824,555 GBP2025-03-31
33,498,868 GBP2024-03-31
32,556,616 GBP2023-04-01
Equity
36,973,555 GBP2025-03-31
35,647,868 GBP2024-03-31
34,705,616 GBP2023-04-01
Profit/Loss
Retained earnings (accumulated losses)
1,325,687 GBP2024-04-01 ~ 2025-03-31
942,252 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Depreciation rate used
Plant and equipment
102024-04-01 ~ 2025-03-31
Motor vehicles
252024-04-01 ~ 2025-03-31
Office equipment
252024-04-01 ~ 2025-03-31
Computers
252024-04-01 ~ 2025-03-31
Audit Fees/Expenses
21,480 GBP2024-04-01 ~ 2025-03-31
20,650 GBP2023-04-01 ~ 2024-03-31
Wages/Salaries
1,540,395 GBP2024-04-01 ~ 2025-03-31
1,669,652 GBP2023-04-01 ~ 2024-03-31
Social Security Costs
99,018 GBP2024-04-01 ~ 2025-03-31
118,373 GBP2023-04-01 ~ 2024-03-31
Staff Costs/Employee Benefits Expense
1,650,674 GBP2024-04-01 ~ 2025-03-31
1,800,636 GBP2023-04-01 ~ 2024-03-31
Director Remuneration
47,281 GBP2024-04-01 ~ 2025-03-31
46,122 GBP2023-04-01 ~ 2024-03-31
Tax Expense/Credit at Applicable Tax Rate
374,332 GBP2024-04-01 ~ 2025-03-31
316,461 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
221,910 GBP2025-03-31
140,189 GBP2024-03-31
Motor vehicles
255,285 GBP2025-03-31
255,285 GBP2024-03-31
Office equipment
597,769 GBP2025-03-31
543,473 GBP2024-03-31
Computers
16,109 GBP2025-03-31
16,109 GBP2024-03-31
Property, Plant & Equipment - Gross Cost
1,091,073 GBP2025-03-31
955,056 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
64,997 GBP2024-03-31
Motor vehicles
164,079 GBP2024-03-31
Office equipment
468,909 GBP2024-03-31
Computers
15,859 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
713,844 GBP2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
11,013 GBP2024-04-01 ~ 2025-03-31
Motor vehicles, Owned/Freehold
22,801 GBP2024-04-01 ~ 2025-03-31
Office equipment, Owned/Freehold
28,640 GBP2024-04-01 ~ 2025-03-31
Owned/Freehold
62,516 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
76,010 GBP2025-03-31
Motor vehicles
186,880 GBP2025-03-31
Office equipment
497,549 GBP2025-03-31
Computers
15,921 GBP2025-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
776,360 GBP2025-03-31
Property, Plant & Equipment
Plant and equipment
145,900 GBP2025-03-31
75,192 GBP2024-03-31
Motor vehicles
68,405 GBP2025-03-31
91,206 GBP2024-03-31
Office equipment
100,220 GBP2025-03-31
74,564 GBP2024-03-31
Computers
188 GBP2025-03-31
250 GBP2024-03-31
Investments in Subsidiaries
100 GBP2025-03-31
100 GBP2024-03-31
Finished Goods/Goods for Resale
6,588,600 GBP2025-03-31
4,905,610 GBP2024-03-31
Amounts Owed by Group Undertakings
Current
18,858,869 GBP2025-03-31
19,521,341 GBP2024-03-31
Other Debtors
Current
4,186,582 GBP2025-03-31
3,226,750 GBP2024-03-31
Prepayments/Accrued Income
Current
42,772 GBP2025-03-31
32,197 GBP2024-03-31
Cash and Cash Equivalents
94,731 GBP2025-03-31
211,706 GBP2024-03-31
Trade Creditors/Trade Payables
Current
3,141,722 GBP2025-03-31
1,780,307 GBP2024-03-31
Amounts owed to group undertakings
Current
1,267,906 GBP2025-03-31
2,628,658 GBP2024-03-31
Corporation Tax Payable
Current
741,311 GBP2025-03-31
826,475 GBP2024-03-31
Taxation/Social Security Payable
Current
29,897 GBP2025-03-31
393,316 GBP2024-03-31
Other Creditors
Current
858,568 GBP2025-03-31
849,318 GBP2024-03-31
Accrued Liabilities/Deferred Income
Current
415,428 GBP2025-03-31
130,083 GBP2024-03-31
Creditors
Current
7,931,925 GBP2025-03-31
8,375,758 GBP2024-03-31
Net Deferred Tax Liability/Asset
-4,684,416 GBP2025-03-31
-4,684,416 GBP2024-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
52,913 shares2025-03-31
52,913 shares2024-03-31
Par Value of Share
Class 1 ordinary share
0.0102024-04-01 ~ 2025-03-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
779,477 shares2025-03-31
779,477 shares2024-03-31
Par Value of Share
Class 2 ordinary share
0.0102024-04-01 ~ 2025-03-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
802,087 shares2025-03-31
802,087 shares2024-03-31
Par Value of Share
Class 3 ordinary share
0.0102024-04-01 ~ 2025-03-31
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
1,365,523 shares2025-03-31
1,365,523 shares2024-03-31
Par Value of Share
Class 4 ordinary share
0.0102024-04-01 ~ 2025-03-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
9,184 GBP2025-03-31
9,184 GBP2024-03-31
Between one and five year
7,653 GBP2025-03-31
16,837 GBP2024-03-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
16,837 GBP2025-03-31
26,021 GBP2024-03-31
Related profiles found in government register
  • PHARMACEUTICALS DIRECT LIMITED
    Info
    Registered number 03884028
    Old Station Road, Loughton IG10 4PL
    PRIVATE LIMITED COMPANY incorporated on 1999-11-25 (26 years 5 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-11-25
    CIF 0
  • PHARMACEUTICALS DIRECT LIMITED
    S
    Registered number 03884028
    Haslers, Old Station Road, Loughton, Essex, England, IG10 4PL
    Limited Company in England And Wales Companies Registry, England And Wales
    CIF 1
child relation
Offspring entities and appointments 1
  • 1
    BEMIN LIMITED
    - now 04032993
    PHARMACEUTICALS DIRECT (DISTRIBUTION) LTD - 2001-05-11
    Ambe House, Commerce Way, Edenbridge, Kent, United Kingdom
    Active Corporate (5 parents)
    Person with significant control
    2016-04-06 ~ now
    CIF 1 - Ownership of voting rights - 75% or more → OE
    CIF 1 - Ownership of shares – 75% or more → OE

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.